Doby

//Dobrinka Encheva

About Dobrinka Encheva

This author has not yet filled in any details.
So far Dobrinka Encheva has created 187 blog entries.

New VC fund to set sights on Israeli tech for eye diseases

Dr. Barak Azmon, an ophthalmologist and serial entrepreneur, is convinced Israel can become a 'meaningful player' in vision-related developments By SHOSHANNA SOLOMON| April 2018, 12:31 pm | Times of Israel Illustrative image of a patient at an optometrist (nd3000, iStock by Getty Images) Dr. Barak Azmon, an ophthalmologist and serial entrepreneur, is convinced Israel can [...]

By | 2018-04-12T10:13:36+00:00 April 9th, 2018|PR|Comments Off on New VC fund to set sights on Israeli tech for eye diseases

MIXiii-Biomed 2018 – Registration and program online

MIXiii-Biomed 2018 – Registration and program online MIXiii-Biomed 2018 is fast approaching. This prestigious conference and exhibition is once again ready to launch start-ups into the international arena and to help thousands of delegates connect and establish strong networking possibilities. REGISTER NOW Use this opportunity to participate and become a key player in the [...]

By | 2018-04-09T14:44:26+00:00 April 5th, 2018|News|Comments Off on MIXiii-Biomed 2018 – Registration and program online

Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization

Dr. Arie Belldegrun, formerly Kite Pharma’s CEO, and Executive Chairman of Allogene Therapeutics, will be delivering the opening plenary talk at MIXiii-BIOMED conference, May 15-17, Tel Aviv.by john carroll — on April 3, 2018 08:00 AM EDTYou need a license to cut-and-paste this copyrighted news content.Use this link to purchase your paid subscription ($200/year for individuals and $1,000/year for companies of [...]

By | 2018-04-04T09:24:54+00:00 April 4th, 2018|PR|Comments Off on Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization

MIXiii-BIOMED 2018: Introducing the Best of Israel’s Life Science Innovations

Israel's 17th national life science and technology week to be held on May 15-17, 2018 at the David InterContinental Hotel in Tel Aviv NEWS PROVIDED BY MIXiii-BIOMED 07:30 ET | TEL AVIV, Israel, April 3, 2018 /PRNewswire/ The 17th annual MIXiii-BIOMED 2018, the premier international life science conference in Israel, will take place between May 15-17, 2018, at the David InterContinental Hotel in Tel [...]

By | 2018-04-03T16:21:07+00:00 April 3rd, 2018|PR|Comments Off on MIXiii-BIOMED 2018: Introducing the Best of Israel’s Life Science Innovations

MedImmune to Develop Compugen Immuno-Oncology Antibodies

April 2, 2018 | GEN News Highlights AstraZeneca’s #MedImmune subsidiary has agreed to exclusively license and develop #bispecific and multispecific #immuno-oncology antibody products from Compugen’s pipeline, through a collaboration that #Compugen said today could generate for it up to $210 million-plus. Compugen said it will grant MedImmune an exclusive license to develop bispecific and multispecific antibody products [...]

By | 2018-04-03T10:16:27+00:00 April 3rd, 2018|Blog|Comments Off on MedImmune to Develop Compugen Immuno-Oncology Antibodies

InSight #Biopharmaceuticals Buys #Cancer #Treatment Company CureTech

As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced #clinical trials Lilach Baumer17:4228.03.18 Pharmaceutical company InSight Biopharmaceuticals Ltd. has signed a deal to acquire cancer treatment company CureTech Ltd. The announcement was made Wednesday by Clal Biotechnology Industries, which holds 53% of CureTech’s shares. As [...]

By | 2018-03-29T17:21:24+00:00 March 29th, 2018|Blog|Comments Off on InSight #Biopharmaceuticals Buys #Cancer #Treatment Company CureTech

#Medical #devices sector shows signs of recovery

  MIXiii-#BIOMED 2018 #Conference chair Ruti Alon: The pendulum has to move back to medical devices, after a decade in which the sector was starved of financing. For almost a decade, companies in the medical devices sector have lacked financing. Is this era about to end? A report published this month by rating agency [...]

By | 2018-03-28T12:21:46+00:00 March 28th, 2018|PR|Comments Off on #Medical #devices sector shows signs of recovery

Cabinet approves NIS 922m for digital health project

The ambitious plan is designed to make Israel a digital health power and improve the health of its residents, and of the entire world. Israel's cabinet today approved a NIS 922 million budget for a national digital health project. The plan includes a number of elements, the combination of which is designed to make [...]

By | 2018-03-26T11:17:10+00:00 March 26th, 2018|Blog|Comments Off on Cabinet approves NIS 922m for digital health project

Call for companies to present their activities in MIXiii-BIOMED 2018 (Hebrew)

קול קורא לחברות להציג את פעילותן במסגרת MIXiii-BIOMED 2018 BY MENACHEM MAROM  | מרץ 19, 2018 באירוע המוביל של תעשיית מדעי החיים בישראל, תינתן לחברות בתחום הזדמנות להציג את פעילותן לעיניי בכירי התעשייה מהעולם ומישראל. הגשת תקצירים באתר MIXiii-BIOMED תתאפשר עד ליום 9 באפריל,2018 MIXiii-BIOMED – 15 – 17 במאי, 2018, במלון דיוויד אינטרקונטיננטל, תל אביב מארגני [...]

By | 2018-03-25T12:30:51+00:00 March 25th, 2018|PR|Comments Off on Call for companies to present their activities in MIXiii-BIOMED 2018 (Hebrew)

Israel’s Vision For The Future: Investors Open Eyes To Ophthalmology

21 Mar 2018 | ANALYSIS                                     Catherine Longworth, Medtech Insight reporter As the global population ages, the demand for #ophthalmicDevices is expected to rise significantly. #Medtech Insight meets with some of Israel's industry leaders who are developing cutting edge technologies [...]

By | 2018-03-28T16:17:55+00:00 March 22nd, 2018|News|Comments Off on Israel’s Vision For The Future: Investors Open Eyes To Ophthalmology